Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy of **antipsychotics** (a class of drugs used to manage psychosis, including schizophrenia and bipolar disorder) and **levothyroxine sodium** (a synthetic thyroid hormone used to treat hypothyroidism). This combination may be used in certain clinical settings, such as treating psychosis related to hypothyroidism ("myxedema madness") or as augmentation in refractory schizophrenia. Antipsychotics act primarily by modulating neurotransmitter receptors (e.g., dopamine D2, serotonin 5-HT2A). Levothyroxine sodium acts by replacing or supplementing endogenous thyroxine (T4) to normalize metabolic and neurological function. Risperidone, quetiapine, and clozapine are examples of antipsychotics sometimes combined with levothyroxine sodium[3][5]. The combination can have complex endocrine and psychiatric interactions, sometimes speeding psychiatric recovery in patients with hypothyroidism or occasionally as an augmentation strategy in refractory psychosis[3][5]. Careful monitoring of thyroid function, cardiac status, and psychiatric symptoms is recommended.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on antipsychotics + levothyroxine sodium.